Biohaven Pharmaceutical Holding Co Ltd (BHVN): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 06.03.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Preis (06.03.2026) | 52W Hoch | 52W Tief |
| 9,92 | 31,18 | 7,48 |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 20,938 | 11 | 4 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 132.688.489 | 17,77 | 8,28 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Biohaven Pharmaceutical Holding Co Ltd
Mitarbeiter 274
Handelsplatz NYSE
Ticker Symbol BHVN
IPO Datum 2022-09-23
Adresse 215 Church Street, New Haven, CT, United States, 06510
Webseite https://www.biohaven.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Vladimir Coric M.D. | Chairman & CEO |
| 2 | Mr. Matthew Buten | Chief Financial Officer |
| 3 | Dr. Bruce D. Car DACVP, Ph.D. | Chief Scientific Officer |
| 4 | Ms. Kimberly Gentile | Senior Vice President of Clinical Operations |
| 5 | Ms. Deb Young | Senior Director of Regulatory Affairs & Operations |
| 6 | Mr. George C. Clark C.P.A. | VP & Chief Accounting Officer |
| 7 | Ms. Jennifer Porcelli | Vice President of Investor Relations |
| 8 | Mr. Warren Volles J.D. | General Counsel & Chief Legal Officer |
| 9 | Mr. Clifford Bechtold M.S. | President & GM of Biohaven Ireland Chief Compliance Officer |
| 10 | Mr. John Tilton | Chief Commercial Officer of Rare Diseases |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 7,75% | 0,10 Mrd. undefined |
| 2 | BlackRock Inc | 5,93% | 0,08 Mrd. undefined |
| 3 | HHG PLC | 5,10% | 0,07 Mrd. undefined |
| 4 | Stifel Financial Corp | 4,98% | 0,07 Mrd. undefined |
| 5 | Vanguard Group Inc | 3,31% | 0,04 Mrd. undefined |
| 6 | State Street Corp | 3,21% | 0,04 Mrd. undefined |
| 7 | D. E. Shaw & Co LP | 2,03% | 0,03 Mrd. undefined |
| 8 | FMR Inc | 2,02% | 0,03 Mrd. undefined |
| 9 | JPMorgan Chase & Co | 2,01% | 0,03 Mrd. undefined |
| 10 | BNP Paribas Arbitrage, SA | 1,58% | 0,02 Mrd. undefined |
| 11 | Geode Capital Management, LLC | 1,55% | 0,02 Mrd. undefined |
| 12 | T. Rowe Price Associates, Inc. | 1,51% | 0,02 Mrd. undefined |
| 13 | Schonfeld Strategic Advisors LLC | 1,21% | 0,02 Mrd. undefined |
| 14 | Balyasny Asset Management LLC | 1,20% | 0,02 Mrd. undefined |
| 15 | The Goldman Sachs Group Inc | 1,19% | 0,02 Mrd. undefined |
| 16 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0,99% | 0,01 Mrd. undefined |
| 17 | Qube Research & Technologies | 0,95% | 0,01 Mrd. undefined |
| 18 | Two Sigma Investments LLC | 0,95% | 0,01 Mrd. undefined |
| 19 | MYDA Advisors LLC | 0,94% | 0,01 Mrd. undefined |
| 20 | Schmeidler A R & CO Inc | 0,93% | 0,01 Mrd. undefined |